Zanubrutinib
(Update) Acalabrutinib in CLL and MCL
Obinutuzumab
Update Venetoclax in CLL
NCCN Guidelines for Patients for CLL
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
CLL Society
Patient Power